Metabolites
Displaying compounds 4001 - 4025 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12338 | CDP-DG(16:0/27:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-heptacos-9-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12337 | CDP-DG(16:0/27:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-heptacos-11-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12336 | CDP-DG(16:0/27:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(heptacosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H103N3O15P2 1108.383 | |
| YMDB12335 | CDP-DG(16:0/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(10Z)-heptacos-10-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
| YMDB12334 | CDP-DG(16:0/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(12Z)-hexacos-12-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H99N3O15P2 1092.34 | |
| YMDB12333 | CDP-DG(16:0/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(hexacosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H101N3O15P2 1094.356 | |
| YMDB12332 | CDP-DG(16:0/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-pentacos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H97N3O15P2 1078.313 | |
| YMDB12331 | CDP-DG(16:0/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-pentacos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H97N3O15P2 1078.313 | |
| YMDB12330 | CDP-DG(16:0/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(pentacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C53H99N3O15P2 1080.329 | |
| YMDB12329 | CDP-DG(16:0/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-tetracos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 | |
| YMDB12328 | CDP-DG(16:0/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-tetracos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 | |
| YMDB12327 | CDP-DG(16:0/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(tetracosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H97N3O15P2 1066.302 | |
| YMDB12326 | CDP-DG(16:0/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-tricos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C51H93N3O15P2 1050.259 | |
| YMDB12325 | CDP-DG(16:0/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C51H93N3O15P2 1050.259 | |
| YMDB12324 | CDP-DG(16:0/22:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-docos-9-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
| YMDB12323 | CDP-DG(16:0/22:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
| YMDB12322 | CDP-DG(16:0/22:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(docosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H93N3O15P2 1038.248 | |
| YMDB12321 | CDP-DG(16:0/20:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C48H87N3O15P2 1008.178 | |
| YMDB12320 | CDP-DG(16:0/20:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-icos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C48H87N3O15P2 1008.178 | |
| YMDB12319 | CDP-DG(16:0/20:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C48H89N3O15P2 1010.194 | |
| YMDB12318 | CDP-DG(16:0/18:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H83N3O15P2 980.124 | |
| YMDB12317 | CDP-DG(16:0/18:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H83N3O15P2 980.124 | |
| YMDB12316 | CDP-DG(16:0/18:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(octadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H85N3O15P2 982.14 | |
| YMDB12315 | CDP-DG(16:0/16:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C44H79N3O15P2 952.07 | |
| YMDB12314 | CDP-DG(16:0/16:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-hexadec-11-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C44H79N3O15P2 952.07 |